The DOI matches its Crossref record; 294 of the 294 references it cites were found in a registry or an index.
Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases
Open accessAbstract
Cardiovascular disease is the leading cause of death worldwide. Despite advancements in diagnosis and treatment of cardiovascular disease, the incidence of cardiovascular disease is still rising. Therefore, new lines of medications are needed to treat the growing population of patients with cardiovascular disease. Although the majority of the existing pharmacotherapies for cardiovascular disease are synthesized molecules, natural compounds, such as resveratrol, are also being tested. Resveratrol is a non-flavonoid polyphenolic compound, which has several biological effects. Preclinical studies have provided convincing evidence that resveratrol has beneficial effects in animal models of hypertension, atherosclerosis, stroke, ischemic heart disease, arrhythmia, chemotherapy-induced cardiotoxicity, diabetic cardiomyopathy, and heart failure. Although not fully delineated, some of the beneficial cardiovascular effects of resveratrol are mediated through activation of silent information regulator 1 (SIRT1), AMP-activated protein kinase (AMPK), and endogenous anti-oxidant enzymes. In addition to these pathways, the anti-inflammatory, anti-platelet, insulin-sensitizing, and lipid-lowering properties of resveratrol contribute to its beneficial cardiovascular effects. Despite the promise of resveratrol as a treatment for numerous cardiovascular diseases, the clinical studies for resveratrol are still limited. In addition, several conflicting results from trials have been reported, which demonstrates the challenges that face the translation of the exciting preclinical findings to humans. Herein, we will review much of the preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular disease and provide information about the physiological and molecular signaling mechanisms involved. This article is part of a Special Issue entitled: Resveratrol: Challenges in translating pre-clinical findings to improved patient outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–294 of 294
Liu, Z., Yan, S., Zhang, X., Liu, Z., Zhang, W., Mao, W., Wang, W., Cui, W., Zhang, X., Jia, X., et al. (2005) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2005.04303.x · Cited by 88
Zhong, M., Cheng, G. F., Wang, W., Guo, Y., Zhu, X. Y., & Zhang, J. T. (1999) · Phytomedicine · doi:10.1016/s0944-7113(99)80039-7 · Cited by 88
Cao, X., Luo, T., Luo, X., & Tang, Z. (2014) · Hypertension Research · doi:10.1038/hr.2014.90 · Cited by 88
Deng, Y., Alex, D., Huang, H., Wang, N., Yu, N., Wang, Y., Leung, G., & Lee, S. M. (2010) · Phytotherapy Research · doi:10.1002/ptr.3279 · Cited by 87
Protection against Recurrent Stroke with Resveratrol: Endothelial Protection
Clark, D., Tuor, U. I., Thompson, R. J., Institóris, Á., Kulynych, A. D., Zhang, X., Kinniburgh, D. W., Bari, F., Busija, D. W., & Barber, P. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047792 · Cited by 86
Yashiro, T., Nanmoku, M., Shimizu, M., Inoue, J., & Sato, R. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.11.006 · Cited by 85
Kweon, S. H., Song, J. H., & Kim, T. S. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.147 · Cited by 84
Ras, R. T., Zock, P. L., Zebregs, Y. E. M. P., Johnston, N. R., Webb, D. J., & Draijer, R. (2013) · British Journal Of Nutrition · doi:10.1017/s000711451300161x · Cited by 84
Resveratrol Improves Cardiovascular Function in DOCA-Salt Hypertensive Rats
Chan, V., Fenning, A. S., Iyer, A., Hoey, A. J., & Brown, L. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111794480552 · Cited by 84
Cardio‐Oncology/Onco‐Cardiology
Hong, R., Iimura, T., Sumida, K. N. M., & Eager, R. M. (2010) · Clinical Cardiology · doi:10.1002/clc.20823 · Cited by 83
Resveratrol and Calcium Signaling: Molecular Mechanisms and Clinical Relevance
McCalley, A. E., Kaja, S., Payne, A., & Koulen, P. (2014) · Molecules · doi:10.3390/molecules19067327 · Cited by 83
Wojciechowski, P. W., Juric, D., Louis, X. L., Thandapilly, S. J., Yu, L., Taylor, C. G., & Netticadan, T. (2010) · Journal of Nutrition · doi:10.3945/jn.109.115006 · Cited by 83
Myocardial protection by nitrite
Calvert, J. W., & Lefer, D. J. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp079 · Cited by 82
Kim, S., Kim, C. E., & Kim, M. H. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.10.115 · Cited by 82
Lin, Y., Chen, F., Zhang, J., Wang, T., Wei, X., Wu, J., Feng, Y., Dai, Z., & Wu, Q. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-9977-8 · Cited by 82
Tu, V. C., Bahl, J. J., & Chen, Q. M. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.1101 · Cited by 82
Goh, S. S. C., Woodman, O. L., Pepe, S., Cao, A. H., Qin, C. X., & Ritchie, R. H. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.9.101 · Cited by 82
Adiponectin and Vulnerable Atherosclerotic Plaques
Barseghian, A., Gawande, D., & Bajaj, M. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.11.011 · Cited by 82
Resveratrol: New Avenues for a Natural Compound in Neuroprotection
Pallàs, M., Porquet, D., Vicente, A., & Sanfeliu, C. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319380005 · Cited by 81
Resveratrol Ameliorates Experimental Autoimmune Myocarditis
Yoshida, Y., Shioi, T., & Izumi, T. (2007) · Circulation Journal · doi:10.1253/circj.71.397 · Cited by 81
Toklu, H. Z., Şehırlı, Ö., Erşahin, M., Süleymanoğlu, S., Yiğiner, Ö., Emekli‐Alturfan, E., Yarat, A., Yeğen, B. Ç., & Şener, G. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01197.x · Cited by 80
Resveratrol and diabetic cardiac function: focus on recent in vitro and in vivo studies
Turan, B., Tuncay, E., & Vassort, G. (2012) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-012-9429-0 · Cited by 79
Delucchi, F., Berni, R., Frati, C., Cavalli, S., Graiani, G., Sala, R., Chaponnier, C., Gabbiani, G., Calani, L., Rio, D. D., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039836 · Cited by 79
Chen, Q., Wang, E., Ma, L., & Zhai, P. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-56 · Cited by 79
Gordish, K. L., & Beierwaltes, W. H. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00437.2013 · Cited by 78
Hamza, S. M., & Dyck, J. R. B. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00292 · Cited by 77
Self-citationAkar, F., Uludağ, O. M., Aydın, A., Aytekin, Y. A., Elbeğ, Ş., Tuzcu, M., & Şahin, K. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.03.061 · Cited by 75
Resveratrol, a natural ingredient of grape skin: Antiarrhythmic efficacy and ionic mechanisms
Zhang, Y., Liu, Y., Wang, T., Li, B., Li, H., Wang, Z., & Yang, B. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.124 · Cited by 75
Simão, F., Pagnussat, A. S., Seo, J. H., Navaratna, D., Leung, W., Lok, J. M., Guo, S., Waeber, C., Salbego, C. G., & Lo, E. H. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.2 · Cited by 72
Mohammadshahi, M., Haidari, F., & Soufi, F. G. (2013) · Cardiology Journal · doi:10.5603/cj.a2013.0051 · Cited by 72
Hormetic response of resveratrol against cardioprotection.
Juhász, B., Mukherjee, S., & Das, D. K. (2010) · Europe PMC (PubMed Central) · Cited by 71
Babacanoglu, C., Yildirim, N., Sadı, G., Pektaş, M. B., & Akar, F. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.07.026 · Cited by 71
Shen, M., Wu, R., Zhao, L., Li, J., Guo, H.-T., Fan, R., Cui, Y. R., Wang, Y., Yue, S., & Pei, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051223 · Cited by 71
Chen, Y.-R., Yi, F.-F., Li, X., Wang, C., Chen, L., Yang, X., Su, P., & Cai, J. (2008) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-008-6141-8 · Cited by 70
Resveratrol Improves Ischemia/Reperfusion-Induced Oxidative Renal Injury in Rats
Şener, G., Tuğtepe, H., Yüksel, M., et al. (2006) · Archives of Medical Research · doi:10.1016/j.arcmed.2006.04.003 · Cited by 69
Paffett, M. L., Lucas, S., & Campen, M. J. (2011) · Vascular Pharmacology · doi:10.1016/j.vph.2011.11.002 · Cited by 69
Beaudoin, M., Perry, C. G. R., Arkell, A. M., Chabowski, A., Simpson, J. A., Wright, D. C., & Holloway, G. P. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2013.270538 · Cited by 67
Shalwala, M., Zhu, S., Das, A., Salloum, F. N., Xi, L., & Kukreja, R. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086977 · Cited by 66
Bresciani, L., Calani, L., Bocchi, L., Delucchi, F., Savi, M., Ray, S., Brighenti, F., Stilli, D., & Rio, D. D. (2013) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2013.09.008 · Cited by 65
Protein turnover in cardiac cell growth and survival
Hedhli, N., Pelat, M., & Depre, C. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.06.025 · Cited by 65
Resveratrol reduces infarct size and improves ventricular function after myocardial ischemia in rats
Lin, J.-F., Lin, S.-M., Chih, C.-L., Nien, M.-W., Su, H.-H., Hu, B.-R., Huang, S.-S., & Tsai, S. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.06.016 · Cited by 63
Turrens, J. F., Lariccia, J., & Nair, M. G. (1997) · Free Radical Research · doi:10.3109/10715769709097859 · Cited by 62
Thandapilly, S. J., Louis, X. L., Yang, T., Defries, D. M., Yu, L., Zhang, S., Wigle, J. T., Kardami, E., Zahradka, P. C., Taylor, C. G., et al. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.06.042 · Cited by 61
Arrick, D. M., Sun, H., Patel, K. P., & Mayhan, W. G. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00312.2011 · Cited by 61
Resveratrol inhibits right ventricular hypertrophy induced by monocrotaline in rats
Yang, D., Zhang, H., Xu, Y., Gao, Y., Yang, X., Hao, X., & Li, X. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2009.05231.x · Cited by 60
Protective effect of resveratrol against pressure overload‐induced heart failure
Gupta, P., DiPette, D. J., & Supowit, S. C. (2014) · Food Science & Nutrition · doi:10.1002/fsn3.92 · Cited by 60
Multiple dietary supplements do not affect metabolic and cardiovascular health
Soare, A., Weiss, E. P., Holloszy, J. O., & Fontana, L. (2013) · Aging · doi:10.18632/aging.100597 · Cited by 60
Xu, Q., Hao, X., Yang, Q., & Si, L. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.08.021 · Cited by 59
Maayah, Z. H., Ansari, M. A., Gendy, M. A. M. E., Al-Arifi, M. N., & Korashy, H. M. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1159-5 · Cited by 59
Resveratrol and Small Artery Compliance and Remodeling in the Spontaneously Hypertensive Rat
Behbahani, J., Thandapilly, S. J., Louis, X. L., Huang, Y., Shao, Z., Kopilas, M. A., Wojciechowski, P. W., Netticadan, T., & Anderson, H. D. (2010) · American Journal of Hypertension · doi:10.1038/ajh.2010.161 · Cited by 58
Xuan, W., Wu, B., Chen, C., Chen, B., Zhang, W., Xu, D., Bin, J., & Liao, Y. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e31825fd7da · Cited by 58
Gu, J. F., Song, Z.-P., Dong-mei, G., Hu, W. G., Chen, Y.-G., & Zhang, D. (2012) · Cardiovascular Toxicology · doi:10.1007/s12012-012-9178-7 · Cited by 57
Resveratrol modulates the angiogenic response to exercise training in skeletal muscles of aged men
Gliemann, L., Olesen, J., Biensø, R. S., Schmidt, J. F., Akerstrom, T. C. A., Nyberg, M., Lindqvist, A., Bangsbo, J., & Hellsten, Y. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00168.2014 · Cited by 56
de Lange, D. W., Verhoef, S., Gorter, G., Kraaijenhagen, R. J., van de Wiel, A., & Akkerman, J. N. (2007) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00439.x · Cited by 55
Cardiac Energy Metabolism and Oxidative Stress Biomarkers in Diabetic Rat Treated with Resveratrol
dos Santos, K. C., Braga, C. P., Barbanera, P. O., Seiva, F. R. F., Fernandes, A. A. H., & Fernandes, A. A. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102775 · Cited by 54
Akar, F., Pektaş, M. B., Tufan, C., Söylemez, S., Sepici, A., Ulus, A. T., Gokalp, B., Öztürk, K., & Surucu, H. S. (2010) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-010-6255-7 · Cited by 54
The red wine polyphenol, resveratrol, exerts acute direct actions on guinea-pig ventricular myocytes
Liew, R., Stagg, M. A., MacLeod, K. T., & Collins, P. D. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.06.017 · Cited by 54
Effects of trans- and cis-resveratrol on Ca2+ handling in A7r5 vascular myocytes
Campos‐Toimil, M., Elíes, J., Álvarez, E., Verde, I., & Orallo, F. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.08.003 · Cited by 53
Ferroni, P., Della‐Morte, D., Palmirotta, R., McClendon, M. S., Testa, G., Abete, P., Rengo, F., Rundek, T., Guadagni, F., & Roselli, M. (2011) · Rejuvenation Research · doi:10.1089/rej.2010.1141 · Cited by 53
Resveratrol blocks interleukin-18-EMMPRIN cross-regulation and smooth muscle cell migration
Venkatesan, B. A., Valente, A. J., Reddy, V. S., Siwik, D. A., & Chandrasekar, B. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00311.2009 · Cited by 53
Annabi, B., Lord‐Dufour, S., Vézina, A., & Béliveau, R. (2012) · Drug Target Insights · doi:10.4137/dti.s9442 · Cited by 50
Söylemez, S., Sepici, A., & Akar, F. (2009) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-009-6198-z · Cited by 49
Louis, X. L., Thandapilly, S. J., Mohankumar, S. K., Yu, L., Taylor, C. G., Zahradka, P. C., & Netticadan, T. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.06.010 · Cited by 49
Anthracycline-mediated cardiomyopathy: Basic molecular knowledge for the cardiologist
Salazar‐Mendiguchía, J., González‐Costello, J., Roca, J., Ariza‐Solé, A., Manito, N., & Cequier, A. R. (2014) · Archivos de cardiología de México · doi:10.1016/j.acmx.2013.08.006 · Cited by 49
Göçmen, A. Y., Burgucu, D., & Gümüşlü, S. (2011) · Applied Physiology Nutrition and Metabolism · doi:10.1139/h11-022 · Cited by 48
Thandapilly, S. J., Louis, X. L., Behbahani, J., Movahed, A., Yu, L., Fandrich, R. R., Zhang, S., Kardami, E., Anderson, H. D., & Netticadan, T. (2013) · Hypertension Research · doi:10.1038/hr.2013.55 · Cited by 47
AMPK signalling and the control of substrate use in the heart
Nagendran, J., Waller, T. J., & Dyck, J. R. B. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.06.015 · Cited by 47
Self-citationAnti-angiogenic effect of high-dose resveratrol in a swine model of metabolic syndrome
Robich, M. P., Chu, L. M., Chaudray, M., Nezafat, R., Han, Y., Clements, R., Laham, R. J., Manning, W. J., Coady, M. A., & Sellke, F. W. (2010) · Surgery · doi:10.1016/j.surg.2010.04.013 · Cited by 46
Breen, D. M., Dolinsky, V. W., Zhang, H., Ghanim, H., Guo, J., Mroziewicz, M., Tsiani, E., Bendeck, M. P., Dandona, P., Dyck, J. R. B., et al. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.03.021 · Cited by 46
Self-citationResveratrol in the Prevention and Treatment of Coronary Artery Disease
Chu, L. M., Lassaletta, A. D., Robich, M. P., & Sellke, F. W. (2011) · Current Atherosclerosis Reports · doi:10.1007/s11883-011-0202-3 · Cited by 44
Zhou, L., Deng, W., Zhou, L., Fang, P., He, D., Zhang, W., Liu, K., & Hu, R. (2009) · Current Diabetes Reviews · doi:10.2174/157339909788920938 · Cited by 44
Baczkó, I., Liknes, D. A., Yang, W., Hamming, K. S. C., Searle, G. J., Jaeger, K., Husti, Z., Juhász, V., Klausz, G., Pap, R., et al. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12409 · Cited by 43
Self-citationChen, C., Wang, Y., Xueding, C., Zhang, Q., Huang, X., Xu, H., Yu, F., Chen, C., Yuanyuan, L., Zhang, W., et al. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.03.008 · Cited by 43
Yang, Y.-M., Chen, J.-Z., Wang, X., Wang, S., Hu, H., & Wang, H. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.01.009 · Cited by 43
Wang, D., Xu, Y., & Liu, W. (2008) · Phytomedicine · doi:10.1016/j.phymed.2008.02.009 · Cited by 43
The vasorelaxing effect of resveratrol on abdominal aorta from rats and its underlying mechanisms
Shen, M., Zhao, L., Wu, R., Yue, S., & Pei, J. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.07.005 · Cited by 42
Dolinsky, V. W., & Dyck, J. R. B. (2014) · Molecules · doi:10.3390/molecules190914919 · Cited by 41
Self-citationQian, C., Ma, J., Zhang, P., Luo, A., Wang, C., Ren, Z., Kong, L., Zhang, S., Wang, X., & Wu, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051358 · Cited by 38
Resveratrol provoca efeitos antiaterogênicos em um modelo animal de aterosclerose
Matos, R. S., Baroncini, L. A. V., Précoma, L. B., Winter, G., Lambach, P. H., Caron, Kaiber, F., & Précoma, D. B. (2012) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2012005000006 · Cited by 38
Vascular and Cardiac Effects of Grape Powder in the Spontaneously Hypertensive Rat
Thandapilly, S. J., Stobart, J. L., Louis, X. L., Anderson, C. M., Netticadan, T., & Anderson, H. D. (2012) · American Journal of Hypertension · doi:10.1038/ajh.2012.98 · Cited by 38
Zordoky, B. N. M., & El‐Kadi, A. O. S. (2009) · Toxicology in Vitro · doi:10.1016/j.tiv.2009.12.002 · Cited by 36
Self-citationMaruyoshi, H., Funahashi, T., Miyamoto, S., Hokamaki, J., Soejima, H., Sakamoto, T., Kawano, H., Yoshimura, M., Kitagawa, A., Matsuzawa, Y., et al. (2004) · Thrombosis and Haemostasis · doi:10.1160/th03-12-0731 · Cited by 34
Subramanian, M., Balasubramanian, P., Garver, H. S., Northcott, C. A., Zhao, H., Haywood, J. R., Fink, G. D., MohanKumar, S. M. J., & MohanKumar, P. S. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00020.2011 · Cited by 31
Tonkin, A. M., & Byrnes, A. (2014) · F1000Prime Reports · doi:10.12703/p6-17 · Cited by 30
The effect of resveratrol on blood pressure in a rat model of preeclampsia
Tekın, Ö. M., Üstün, Y. E., Tonguc, E. A., Var, T., Tapısız, Ö. L., Ergün, H., Güvenç, T., & Gacar, A. (2011) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2011.599081 · Cited by 29
Hypertensive Cardiovascular and Renal Disease and Target Organ Damage: Lessons from Animal Models
Sušić, D., & Frohlich, E. D. (2011) · Cardiorenal Medicine · doi:10.1159/000329334 · Cited by 25
El‐Mowafy, A. M., Alkhalaf, M., & El‐Kashef, H. A. (2007) · Archives of Medical Research · doi:10.1016/j.arcmed.2007.09.010 · Cited by 25
İkizler, M., Ovalı, C., Dernek, S., Erkasap, N., Sevin, B., Kaygısız, Z., & Kural, T. (2006) · PubMed · Cited by 22
Zheng, J.-P., Ju, D., Jiang, H., Shen, J., Yang, M., & Li, L. (2010) · Toxicology Letters · doi:10.1016/j.toxlet.2010.08.010 · Cited by 21
Wine, sirtuins and nephroprotection: Not only resveratrol
Mannari, C., Bertelli, A. A. E., Stiaccini, G., & Giovannini, L. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2010.08.004 · Cited by 19
Shi, Y., Hou, X., Zhang, X., Wang, Y., Chen, Y., & Zou, J. (2013) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf4036723 · Cited by 19
Anti-Angiogenic Effects of Resveratrol on Cerebral Angiogenesis
Chen, P., & Easton, A. S. (2011) · Current Neurovascular Research · doi:10.2174/156720211794520233 · Cited by 15
Novel Anti-arrhythmic Medications in the Treatment of Atrial Fibrillation
Saklani, P., & Skanes, A. C. (2012) · Current Cardiology Reviews · doi:10.2174/157340312803760785 · Cited by 13
The Protective Effects of Resveratrol and l-NAME on Visceral Organs following Aortic Clamping
Budak, A. B., Seren, M., Turan, N. N., Sakaogullari, Z., & Ulus, A. T. (2009) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2009.04.003 · Cited by 9
Cited by
Antioxidant effects of resveratrol in the cardiovascular system
Xia, N., Daiber, A., Förstermann, U., & Li, H. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13492 · Cited by 574
Health benefits of resveratrol: Evidence from clinical studies
Singh, A. P., Singh, R., Verma, S. S., Rai, V., Kaschula, C. H., Maiti, P., & Gupta, S. C. (2019) · Medicinal Research Reviews · doi:10.1002/med.21565 · Cited by 523
Ali, M. Y., Sina, A. A. I., Khandker, S. S., Neesa, L., Tanvir, E. M., Kabir, A., Khalil, M. I., & Gan, S. H. (2020) · Foods · doi:10.3390/foods10010045 · Cited by 504
Resveratrol and Cardiovascular Diseases
Bonnefont-Rousselot, D. (2016) · Nutrients · doi:10.3390/nu8050250 · Cited by 442
Biological Activities of Stilbenoids
Akinwumi, B., Bordun, K.-A., & Anderson, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030792 · Cited by 373
Metadata
- Authors
- Zordoky, B. N. M., Robertson, I. M., & Dyck, J. R. B.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 1852
- Issue
- 6
- Pages
- 1155-1177
- ISSN
- 0925-4439 (ISSN-L)
- OpenAlex
- W1994643898
- Cited by
- 335
- References
- 294
- FWCI
- 11.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.